Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Varenicline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 9 Tobacco Use Disorder 3 Neoplasms 3 Lung Neoplasms 3 Tobacco Use Cessation 2 Squamous Cell Carcinoma of Head and Neck 2 Smoking 2 Head and Neck Neoplasms 2 Vaping 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tobacco Smoking 1 Pain 1 Neoplasms, Second Primary 1 Nasopharyngeal Carcinoma 1 Cigarette Smoking 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Behavior, Addictive 1 Agnosia 1

Interventions

Drug Therapy 3 Temozolomide 2 Radiotherapy 2 Radiosurgery 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 dostarlimab 1 beta Carotene 1 avelumab 1 alpha-Tocopherol 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Panitumumab 1 Nicotine Chewing Gum 1 Myofascial Release Therapy 1 Megestrol Acetate 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡